1-2 of 2
Valerie Campello-Iddison
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Rationale for the Use of Crizanlizumab (SEG101) in Myelofibrosis

Paola Verachi, Fabrizio Martelli, PhD, Maria Zingariello, PhD, Shalini Chaturvedi, Celine Wilke, MD, Valerie Campello-Iddison, MD, Anna Rita Migliaccio, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-133896
Published: 2020
Journal Articles

Improved Safety with the Use of Subcutaneous Bortezomib in Combination with Panobinostat and Dexamethasone: Preliminary Data from a Panobinostat Global Expanded Treatment Protocol

Andreas Guenther, MD, Lars-Olof Mügge, Mathias Haenel, MD, Fredrik H. Schjesvold, MD, Daniel Lechner, Sameer Yaser, Holger Hebart, MD, Heinz Gisslinger, Richard Greil, MD, Eberhard Gunsilius, MD, Martin Goerner, MD, Katja Weisel, Jan Dürig, MD, Mohamed Elemary, MD MSc,PhD, Denise Wolleschak, Stefan A. Klein, MD, Markus Munder, MD, Alexander Kiani, Hareth Nahi, Christian Junghanss, MD, Valerie Campello-Iddison, MD, Ythier Deniau, Xiaoshu Feng, Hermann Einsele, MD
Journal: Blood
Blood (2016) 128 (22): 5692.
https://doi.org/10.1182/blood.V128.22.5692.5692
Published: 2016